Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Osteoporosis
•
Endocrinology
•
Geriatric Medicine
•
General Primary Care
When (if ever) would you consider starting bisphosphonate therapy for patients with osteopenia but without a high risk fracture history? What patient characteristics would push you to do so?
Related Questions
Would you use a parathyroid hormone analog for treatment of osteoporosis in a patient with mildly elevated AlkPhos of unclear etiology?
What are some practical tips in distinguishing between metabolic bone disease due to chronic kidney disease and osteoporosis?
What patient factors are most important when considering who needs a broader workup for osteoporosis prior to starting therapy?
Do you recommend vitamin K2 supplements in patients with osteoporosis?
What is your approach to the use of GLP-1 agonists in older adults with diabetes with or at risk of sarcopenia?
Would you start romosozumab in an active smoker?
How soon after a fracture would it be safe to start anti-resorptive therapy?
When stopping denosumab and transitioning to PO bisphosphonate, do you wait for 6 months after the last denosumab injection to start PO bisphosphonate?
What is your approach to bisphosphonate use in patients with advanced chronic kidney disease and osteoporosis?
How do you approach decision-making around initiation of osteoporosis therapy in patients with advanced dementia?
